Infliximab antibody | AbD18391
A microtiter plate was coated overnight with human TNFα and infliximab at a concentration of 5 µg/ml. After washing and blocking with PBST + 5% BSA, infliximab/TNFα complex was formed by addition of infliximab at 5 µg/ml in PBST. After washing with PBST, detection was performed using Human Anti-Infliximab (Drug/Target complex) Antibody, clone AbD18391ad (TZA009) titrated to the given concentrations in PBST followed by an HRP conjugated Mouse Anti-His tag Antibody (MCA5995P) in HISPEC Assay Diluent (BUF049A) and QuantaBlu Fluorogenic Peroxidase Substrate. Data for infliximab/TNFα (complex) are shown as the mean of three measurements.
A microtiter plate was coated overnight with human TNFα at a concentration of 5 µg/ml. After washing and blocking with PBST + 5% BSA, 10% human serum was added spiked with increasing concentrations of infliximab. Detection was performed using Human Anti-Infliximab (Drug/Target complex) Antibody, clone AbD18391ad (TZA009) at a concentration of 1 μg/ml followed by HRP conjugated Mouse Anti-His tag Antibody (MCA5995P) in HISPEC Assay Diluent (BUF049A) and QuantaBlu Fluorogenic Peroxidase Substrate. Data are shown as the mean of three measurements.
A microtiter plate was coated overnight with human TNFα and infliximab at a concentration of 5 µg/ml. After washing and blocking with PBST + 5% BSA, infliximab/TNFα (complex) was formed by addition of infliximab at 5 µg/ml in PBST. After washing with PBST, detection was performed using Human Anti-Infliximab (Drug/Target complex) Antibody, clone AbD18391pap (TZA009P) titrated to the given concentrations in HISPEC Assay Diluent (BUF049A) and QuantaBlu Fluorogenic Peroxidase Substrate. Data for infliximab/TNFα (complex) are shown as the mean of three measurements.
A microtiter plate was coated overnight with human TNFα at a concentration of 5 µg/ml. After washing and blocking with PBST + 5% BSA, 10% human serum was added spiked with increasing concentrations of infliximab. Detection was performed using Human Anti-Infliximab (Drug/Target complex) Antibody, clone AbD18391pap (TZA009P) at a concentration of 0.25 μg/ml in HISPEC Assay Diluent (BUF049A) and QuantaBlu Fluorogenic Peroxidase Substrate. Data are shown as the mean of three measurements.
A microtiter plate was coated overnight with various antigens at a concentration of 5 μg/ml. After washing and blocking with PBST + 5% BSA, detection was performed using Human Anti-Infliximab (Drug/Target complex) Antibody, clone AbD18391ad (TZA009) at a concentration of 2 μg/ml followed by an HRP conjugated Anti- DYKDDDDK tag Antibody in HISPEC Assay Diluent (BUF049A) followed by QuantaBlu Fluorogenic Peroxidase Substrate.
Filter by Application:
E ResetHuman anti Infliximab (Drug/Target Complex):HRP
- Product Type
- Monoclonal Antibody
- Clone
- AbD18391
- Isotype
- Fab antibody
- Specificity
- Infliximab
- Region
- DRUG/TARGET COMPLEX
Antibody Quality and Performance Guarantee
| Human Anti-Infliximab (Drug/Target Complex) Antibody, clone AbD18391 specifically recognizes the antibody drug infliximab when in complex with its target, TNFα (cytokine “tumour necrosis factor-alpha”). At defined experimental levels, the antibody does not recognize free infliximab nor unbound recombinant human TNFα. However, as levels greatly increase, detection is noted. It can be used to measure levels of infliximab in patient samples. This TrailBlazer Antibody is available in two different formats, monovalent Fab unconjugated (TZA009) and bivalent Fab conjugated to HRP (TZA009P). The monovalent recombinant Fab antibody has a SpyTag incorporated, which is used to create the bivalent format by coupling two SpyTagged Fab antibodies to an HRP conjugated BiSpyCatcher2 (TZC002P). Either format can be used to develop a pharmacokinetic (PK) antigen capture assay to measure free infliximab captured via immobilized TNFα. The antibody is tagged with a SpyTag2 at the C-terminus of the Fab antibody heavy chain, enabling the user to couple it to any of the SpyCatchers available in our catalog for conversion to alternative formats in less than one hour. View a summary of all SpyCatcher products Infliximab (Remicade) is a chimeric IgG1/kappa antibody. It has been approved for the treatment of psoriasis, Crohn’s Disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis and ulcerative colitis. Infliximab acts by blocking the binding of TNFα to TNF receptors. Infliximab also causes programmed cell death of TNFα-expressing activated T lymphocytes. View a summary of all anti-infliximab antibodies |
|
- Product Form
- A bivalent human recombinant Fab (lambda light chain) generated by coupling of the monovalent SpyTagged Fab TZA009 with a HRP conjugated BiSpyCatcher version 2 (TZC002P). The coupled antibody has two DYKDDDDK tags and three His6-tags. It contains SpyTag3 peptide (BLP086) in 5-fold molar excess to block any unreacted Catcher sites. This antibody is supplied as a liquid.
- Preparation
- Metal chelate affinity chromatography
- Source
- E.coli
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
- 0.0095% MIT
- Immunogen
- Infliximab/TNFα complex
- Affinity
- The monovalent intrinsic affinity of AbD18391 was measured as KD = 16 nM by real time, label free molecular interaction analysis on immobilized biotinylated infliximab complexed with human TNFα.
- Approx. Protein Concentrations
- Antibody concentration 0.5 mg/ml
- Regulatory
- For research purposes only
- Guarantee
- 12 months from date of despatch
- Acknowledgements
- This product and/or its use is covered by claims of U.S. patents, and/or pending U.S. and non-U.S. patent applications owned by or under license to Bio-Rad Laboratories, Inc. See bio-rad.com/en-us/trademarks for details.
His-tag is a registered trademark of EMD Biosciences.
Remicade is a trademark of Janssen Biotech, Inc. - Licensed Use
- For in vitro research purposes and for commercial applications for the provision of in vitro testing services to support preclinical and clinical drug development. Any re-sale in any form or any other commercial application needs a written agreement with Bio-Rad.
This product is shipped frozen.
When ready to use, thaw and aliquot the sample as needed. Store aliquots at -70°C, if available, otherwise store at -20°C. It is not recommended to keep aliquots at 4°C for more than one week.
When ready to use, thaw and aliquot the sample as needed. Store aliquots at -70°C, if available, otherwise store at -20°C. It is not recommended to keep aliquots at 4°C for more than one week.
This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
| Application Name | Verified | Min Dilution | Max Dilution |
|---|---|---|---|
| ELISA |  |
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
- Technical Advice
- Recommended protocols for coupling a Fab antibody with a SpyTag to a SpyCatcher can be found at SpyTag and SpyCatcher Products, and further information about HuCAL recombinant antibody technology can be found in the HuCAL Antibodies Technical Manual
- ELISA
- Clone AbD18391pap can be used in a direct ELISA to detect the infliximab/TNFα complex or as the detection antibody for infliximab captured on immoblized TNFα in a PK antigen capture ELISA.
Protocol: PK antigen capture ELISA to measure bound drug exclusively.
| Description | Product Code | Applications | Pack Size | List Price | Your Price | Quantity | |
|---|---|---|---|---|---|---|---|
| Hispec Assay Diluent | BUF049A | E IY | 50 ml | Log in | |||
| List Price | Your Price | ||||||
| Log in | |||||||
| Description | Hispec Assay Diluent | ||||||
| Human anti Infliximab | HCA212 | E | 0.1 mg |
|
Log in | ||
| List Price | Your Price | ||||||
|
|
Log in | ||||||
| Description | Human anti Infliximab | ||||||
| Human anti Infliximab | HCA213 | E | 0.1 mg |
|
Log in | ||
| List Price | Your Price | ||||||
|
|
Log in | ||||||
| Description | Human anti Infliximab | ||||||
| Human anti Infliximab | HCA214 | E | 0.1 mg |
|
Log in | ||
| List Price | Your Price | ||||||
|
|
Log in | ||||||
| Description | Human anti Infliximab | ||||||
| Human anti Infliximab | HCA215 | E | 0.1 mg |
|
Log in | ||
| List Price | Your Price | ||||||
|
|
Log in | ||||||
| Description | Human anti Infliximab | ||||||
| Human anti Infliximab | HCA216 | E | 0.1 mg |
|
Log in | ||
| List Price | Your Price | ||||||
|
|
Log in | ||||||
| Description | Human anti Infliximab | ||||||
| Human anti Infliximab | HCA233 | E | 0.1 mg |
|
Log in | ||
| List Price | Your Price | ||||||
|
|
Log in | ||||||
| Description | Human anti Infliximab | ||||||
| Human anti Infliximab | HCA234 | E | 0.1 mg |
|
Log in | ||
| List Price | Your Price | ||||||
|
|
Log in | ||||||
| Description | Human anti Infliximab | ||||||
| Human anti Infliximab (Drug/Target Complex) | TZA009 | E | 0.1 mg |
|
Log in | ||
| List Price | Your Price | ||||||
|
|
Log in | ||||||
| Description | Human anti Infliximab (Drug/Target Complex) | ||||||
- Synonyms
- Remicade
TZA009P
165711
If you cannot find the batch/lot you are looking for please contact our technical support team for assistance.
View more products with INFLIXIMAB specificity
Please Note: All Products are "FOR RESEARCH PURPOSES ONLY"
Always be the first to know.
When we launch new products and resources to help you achieve more in the lab.
Yes, sign me up